The Claim
In adults with bicuspid aortic valve and no severe valvular dysfunction, daily treatment with 20 mg of atorvastatin for three years does not reduce the progression of ascending aorta dilation as measured by computed tomography, despite significantly lowering low-density lipoprotein cholesterol levels.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with a bicuspid aortic valve and no severe valve problems, taking 20 mg of atorvastatin daily for three years does not slow the widening of the ascending aorta, even though it lowers LDL cholesterol levels.
See the scientific wording
In adults with bicuspid aortic valve and no severe valvular dysfunction, daily treatment with 20 mg of atorvastatin for three years does not reduce the progression of ascending aorta dilation, as measured by computed tomography, despite significantly lowering low-density lipoprotein cholesterol levels.
Taking atorvastatin reduces bad cholesterol in the blood, but the wall of the main artery leaving the heart continues to stretch over time because the underlying structural weakness from the abnormal valve does not change, and the cholesterol-lowering effect does not stop the cells in the artery wall from breaking down and rebuilding tissue in a way that lets the artery grow.
What the research says
1 studyEven though the pill lowered bad cholesterol, it didn’t make the main artery leaving the heart grow any slower in people with this specific heart valve condition. The artery grew just as much in people who took the pill as in those who took a sugar pill.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.